COMMUNIQUÉS West-GlobeNewswire
-
Leviton Canada donates $100,000 to the Lachine Hospital Foundation to expand services and care in the West Island
23/07/2024 - 15:33 -
Leviton Canada fait un don de 100 000 $ à la Fondation de l’Hôpital de Lachine pour améliorer les services et les soins dans l’Ouest-de-l’Île
23/07/2024 - 15:33 -
Virios Therapeutics Announces Completion of Enrollment in IMC-2 Phase 2 Long-COVID Study Being Conducted by Bateman Horne Center
23/07/2024 - 15:15 -
Novogene to Power Cancer, Rare Disease, and Environmental Research with PacBio Sequencing
23/07/2024 - 15:05 -
Precision Neuroscience Expands Executive Team as Brain–Computer Interface Industry Rapidly Advances
23/07/2024 - 15:00 -
Scilex Holding Company Strengthens Board of Directors with Appointment of Highly Accomplished Leader in Interventional and Multidisciplinary Spine, Musculoskeletal and Orthopedic Care, Annu Navani, M.D.
23/07/2024 - 15:00 -
Electric is the Future: Chronus Health to Unveil its Electrical Sensing-Based Blood Testing Technology at ADLM 2024
23/07/2024 - 15:00 -
INmune Bio Inc. Publishes Novel Biology on Natural Killer Cancer Immunotherapy INKmune™ in the Journal for ImmunoTherapy of Cancer
23/07/2024 - 14:45 -
The Canadian Foundation for Women’s Health (CFWH) Launches Comprehensive Effort to Combat Maternal Morbidity and Mortality
23/07/2024 - 14:30 -
Announces Closing of $5.0 Million Registered Direct Offering and Concurrent Private Placement
23/07/2024 - 14:30 -
Milestone Scientific Announces Medicare Price Assignment for the CompuFlo® Epidural System in Texas, Pennsylvania, New Jersey, Maryland, Colorado, Oklahoma, Louisiana, Arkansas, Mississippi, New Mexico, District of Columbia, and Delaware
23/07/2024 - 14:30 -
Adial Pharmaceuticals Advances to Second Cohort in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder
23/07/2024 - 14:30 -
First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s FDA-Approved QUELIMMUNE Therapeutic Device
23/07/2024 - 14:30 -
Cannara Biotech Reports Q3 2024 Financial Results
23/07/2024 - 14:30 -
Cannara Biotech publie ses résultats financiers pour le troisième trimestre de 2024
23/07/2024 - 14:30 -
Kane Biotech Receives FDA Approval to Increase Dosage Allowance of its revyve™ Antimicrobial Wound Gel
23/07/2024 - 14:30 -
Emergent BioSolutions to Release Second Quarter 2024 Financial Results & Conduct Conference Call on August 6, 2024
23/07/2024 - 14:27 -
Vireo Growth Inc. to Release Second Quarter 2024 Results on August 6, 2024
23/07/2024 - 14:01 -
BrainsWay to Report Second Quarter 2024 Financial Results on August 6, 2024
23/07/2024 - 14:00
Pages